Aquestive Therapeutics, Inc. Operating Lease, Liability, Current
Aquestive Therapeutics, Inc. (AQST) had Operating Lease, Liability, Current of $820.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-11
- 2026-06-30: Operating Lease, Liability, Current $820.00K.
- 2026-03-31: Operating Lease, Liability, Current $662.00K.
- 2025-12-31: Operating Lease, Liability, Current $631.00K.
- 2025-09-30: Operating Lease, Liability, Current $601.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $820.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $662.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $631.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $601.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $570.00K 10-Q · filed 2025-08-11 |
| 2025-03-31 | $540.00K 10-Q · filed 2025-05-12 |
| 2024-12-31 | $510.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $482.00K 10-Q · filed 2024-11-04 |
| 2024-06-30 | $455.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $414.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $390.00K 10-K · filed 2025-03-05 |
| 2023-09-30 | $367.00K 10-Q · filed 2023-11-06 |
| 2023-06-30 | $347.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $328.00K 10-Q · filed 2023-05-02 |
| 2022-12-31 | $255.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | $846.00K 10-Q · filed 2022-11-01 |
| 2022-06-30 | $913.00K 10-Q · filed 2022-08-02 |
| 2022-03-31 | $926.00K 10-Q · filed 2022-05-04 |
| 2021-12-31 | $899.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $860.00K 10-Q · filed 2021-11-02 |
| 2021-06-30 | $823.00K 10-Q · filed 2021-08-03 |
| 2021-03-31 | $787.00K 10-Q · filed 2021-05-04 |
| 2020-12-31 | $728.00K 10-K · filed 2022-03-08 |
| 2020-09-30 | $664.00K 10-Q · filed 2020-11-04 |
| 2020-06-30 | $689.00K 10-Q · filed 2020-08-04 |
| 2020-03-31 | $609.00K 10-Q · filed 2020-05-05 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |